DIVA - The up-to-date strategy to control epizootic diseases;DIVA - Die moderne Art der Tierseuchenbekämpfung

Tierarztliche Umschau

Volumn 59, Issue 10, 2004, Pages 551-559

  Beer, M ^a   Mettenleiter, Th ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Avian influenza; Bovine herpesvirus type 1; Classical swine fever; Differentiating infected from vaccinated animals (DIVA); Foot and mouth disease; Marker diagnostics; Marker vaccine

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN E; INACTIVATED VACCINE; INFLUENZA VACCINE; VIRUS VACCINE;

ARTICLE; BIRD DISEASE; BOVINE HERPES VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIZOOTIOLOGY; ERADICATION THERAPY; FOOT AND MOUTH DISEASE; GERMANY; HERPES; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; INFECTION CONTROL; INFLUENZA; NONHUMAN; PROTEIN DEGRADATION; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; SWINE; SWINE DISEASE; VIRION; VIRUS CAPSID;

ANIMALIA; AVES; BOVINAE; BOVINE HERPESVIRUS 1; GALLIFORMES; HERPESVIRIDAE; SUID HERPESVIRUS 1; SUS SCROFA;

EID: 7044262263     PISSN: 00493864     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Barnett, P. V. and H. Carabin (2002): A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20, 1505-1514.
2. Beer, M., P. König, G. Schielke und S. Trapp (2003): Marker diagnostic for the eradication of bovine herpesvirus type 1: Possibilities and limitations. Berl. Münch. Tierärztl. Wschr. 116, 183-191.
3. Bergmann, I. E., V. Malirat, E. Neitzert, E. Beck, N. Panizzutti, C. Sanchez, and A. Falczuk (2000): Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay. Arch. Virol. 145 (3), 473-489.
4. Bouma, A., A. J. de Smit, E. P. De Kluijver, C. Terpstra, and R. J. M. Moormann (1999): Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet. Microbiol. 66, 101-114.
5. Brocchi, E., M. De Diego, A. Berlinzani, D. Gamba, and F. De Simone (1998): Diagnostic potential of Mab-based ELISAs for antibodies to non-structural proteins of foot-and-mouth disease virus to differentiate infection from vaccination. Veterinary Quarterly 20 S2, 20-24.
6. Brown, F. (1992): New approaches to vaccination against foot-and-mouth disease. Vaccine 10, 1022-1026.
7. Callahan, J. D., F. Brown, F. A. Osorio, J. H. Sur, E. Kramer, G. W. Long, Lubroth, J., S. J. Ellis, K. S. Shoulars, K. L. Gaffney, D. L. Rock, and W. M. Nelson (2002): Use of a portable real-time reverse transcriptase- polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J. Am. Vet. Med. Assoc. 220, 1636-42.
8. Capua I. and S. Marangon (2003): Vaccination policy applied for the control of avian influenza in Italy. Dev.Biol. 114, 213-9.
9. Capua, I., G. Cattoli, S. Marangon, L. Bortolotti, G. and Ortali (2002): Strategies for the control of vian influenza in Italy. Vet. Rec. 150 (7), 223.
10. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli and J. F. Rodriguez (2003): Development of a DIVA-Differentiating infected from vaccinated animals- strategy using a vaccine containing a heterologous neruraminidase for the control of avian influenza. Avion Pathology 32, 47-55.
11. CEC (Commission of the European Communities) (2001): Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever.
12. CEC (Commission of the European Communities), (2000): Commission Decision 2000/721/ EC of 7 November 2000 on introducing vaccination to supplement the measures to control avian influenza in Italy and on specific movement control measures.
13. Crawford, J., B. Wilkinson, A. Vosnesensky, G. Smith, M. Garcia, H. Stone, and M. Perdue (1999): Baculovirus- derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17, 2265-2274.
14. De Diego, M., E. Brocchi, D. Mackay, and F. De Simone (1997): The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol. 142, 2021-2033.
15. de Smit, A.J., (2000). Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review. Veterinary Quarterly 22, 182-188.
16. de Smit, A. J., A. Bouma, H. G. van Gennip, E. P. de Kluijver and R. J. Moormann (2001): Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs, Vaccine 19, 1467-1476.
17. Depner, K. R., A. Bouma, F. Koenen, D. Klinkenberg, E. Lange, J. A. de Smit and H. Vanderhallen (2001): Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Vet. Microbiol. 83, 107-120.
18. Dewulf, J., H. Laevens, F. Koenen, K. Minnens and A. de Kruif (2001 ): An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine 20, 86-91.
19. Floegel-Niesmann, G. (2001): Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs. Vet. Microbiol. 83, 121-136.
20. Haas, B. and K. Sørensen (2002): Comparsion of ELISAs for the differentiation of infection from vaccination by detection of antibodies to the non-structural 3ABC protein of FMDV. Session of the Research Group of the Standing Technical Committee of the EUFMD. Izmir, Turkey, 17-20 September 2002.
21. Hulst, M. M., D. F. Westra, G. Wensvoort and R. J. M. Moormann (1993): Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine fever from hog cholera. J. Virol. 67. 5435-5442.
22. Kaashoek, M. J., A. Moerman J. Madic, K. Weerdmeester, M. Maris-Veldhuis, F. A. Rijsewijk and J. T. Oirschot (1995): An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13, 342-6.
23. Kaashoek M. J, A. Moerman, J. Madic, F. A. Rijsewijk, J. Quak, A. L. Gielkens, J. T. van Oirschot (1994): A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type I is an efficacious and safe vaccine. Vaccine 12, 439-44.
24. Lüschow, D., O. Werner, T. C. Mettenleiter and W. Fuchs, (2001): Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19, 4249-4259.
25. Mackay, I. M., K. E. Arden and A. Nitsche, (2002): Real-time PCR in virology. Nucleic Acids Res. 30, 1292-1305.
26. Mettenleiter, T. C. (1995): Progress in the development of vaccines against Aujeszky's disease. Tierärztl. Prax. 23, 570-574.
27. Mettenleiter T. C., N. Lukacs and H. J. Rziha (1985): Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol. 56, 307-311.
28. Müller, T., H. J. Bätza, H. Schlüter, F. J. Conraths and T. C. Mettenleiter (2003): Eradication of Aujeszky's disease in Germany. J. Vet. Med. B 50, 207-213.
29. Reimann, I., K. R. Depner, S. Trapp and M. Beer, (2004): An Avirulent Chimeric Pestivirus With Altered Cell Tropism Protects Pigs Against Lethal Infection With Classical Swine Fever Virus. Virology (in press).
30. Scahaw (Scientific Committee on Animal Health and Animal Welfare) (2003): Diagnostic techniques and vaccines for foot-and-mouth disease, classical swine fever and avian influenza. Report of the Scientific Committee on Animal Health and Animal Welfare, adopted 24-25th April 2003.
31. Scahaw (Scientific Committee on Animal Health and Animal Welfare). (1999): Strategy for emergency vaccination against foot-and-mouth disease (FMD). Report of the Scientific Committee on Animal Health and Animal Welfare, adopted 10 March 1999. http://europa.eu.int/comm/ foodfs/sc/scah/out22_en.pdf
32. Scahaw (Scientific Committee on Animal Health and Animal Welfare). (2000): The definition of avian influenza. The use of vaccination against avian influenza. Report of the Scientific Committee on Animal Health and Animal Welfare. http://europa.eu.int/comm/food/fs/sc/scah/ out45_en.pdf
33. Silberstein, E., G. Kaplan, O. Taboga, S. Duffy, E. and Palma (1997): Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch. Virol. 142, 795-805.
34. Sørensen, K. J., K. G. Madsen, E. S. Madsen, J. S. Salt, J. Nqindi, and D. K. J. Mackay (1998): Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch. Virol. 143, 1461-1476.
35. Spackman, E., D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber, M. L. Perdue, K. Lohman, L. T. Daum and D. L. Suarez (2002): Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40, 3256-3260.
36. Trapp, S., P. König and M. Beer (2003): Conventional and marked BHV-1 vaccines in Germany: A brief review. Berl. Munch. Tierärztl. Wschr. 116, 208-215.
37. Uttenthal, A., M.-F. Le Potier, L. Romero, G. Mario de Mia and G. Floegel-Niesmann, (2001): Classical swine fever (CSF) marker vaccine. Trial 1- Challenge studies in weaner pigs. Vet. Microbiol. 83, 85-106.
38. van Engelenburg, F. A., M. J. Kaashoek, F. A. Rijsewijk, L. van den Burg, A. Moerman, L. Gielkens and J. T. van Oirschot (1994): A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol. 75, 2311-2318.
39. van Oirschot J. T. (2003): Emergency vaccination against classical swine fever. Dev. Biol. 114, 259-267.
40. van Oirschot, J. T. (1999): Diva vaccines that reduce virus transmission. J. Biotechnol. 73, 195-205.
41. van Oirschot J. T., A. L. Gielkens, R. J. Moormann and A. J. Berns (1990): Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet. Microbiol. 23, 85-101.
42. van Oirschot, J. T., H. J. Rziha, P. J. L. M. Moonen, J. M. A. Pol and D. van Zaane (1986): Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 67, 1179-1182.